跳至主要内容
临床试验/NCT01308515
NCT01308515撤回不适用

A Comparative Clinical Evaluation of the Vanguard Knee System's Anterior Stabilized & Posterior Stabilized Tibial Bearings

Zimmer Biomet0 个研究点开始时间: 2010年9月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
撤回
发起方
Zimmer Biomet
主要终点
Objective Knee Score

研究概览

简要总结

The purpose of this study is to compare the performance of two FDA-cleared tibial bearings (replacement for cartilage in the knee) by collecting data on patients through 3 years of follow-up.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •are identical to the indications stated in the FDA approved labeling for the device 510(k) K023546, K033489, and K
  • •These indications are stated below:
  • •Painful and disabled knee joint resulting from osteoarthritis, rheumatoid arthritis, traumatic arthritis where one or more compartments are involved.
  • •Correction of varus, valgus, or posttraumatic deformity.
  • •Correction or revision of unsuccessful osteotomy, or arthrodesis.
  • •Patient selection factors to be considered include:
  • •Need to obtain pain relief and improve function
  • •Ability and willingness of the patient to follow instructions, including control of weight and activity level
  • •A good nutritional state of the patient
  • •The patient must have reached full skeletal maturity

排除标准

  • •will be identical to the contraindications stated in the FDA approved labeling for the device 510(k) K023546, K033489, and K
  • •These contraindications are stated below:
  • •Absolute contraindications include: infection, sepsis, osteomyelitis, and failure of a previous joint replacement.
  • •Relative contraindications include:
  • •Uncooperative patient or patient with neurologic disorders who are incapable of following directions
  • •Osteoporosis,
  • •Metabolic disorders which may impair bone formation
  • •Osteomalacia
  • •Distant foci of infections which may spread to the implant site,
  • •Rapid joint destruction, marked bone loss or bone resorption apparent on roentgenogram,
  • •Vascular insufficiency, muscular atrophy, neuromuscular disease,
  • •Incomplete or deficient soft tissue surrounding the knee

研究组 & 干预措施

Posterior Stabilized

Other

Patients who received a PS (Posterior Stabilized) Tibial Bearing.

干预措施: Vanguard Knee System with PS Bearing (Device)

Anterior Stablized

Other

Patients who received an AS (Anterior Stabilized) Tibial Bearing

干预措施: Vanguard Knee System with AS Bearing (Device)

结局指标

主要结局

Objective Knee Score

时间窗: 1 Year Post-op

Average objective knee score; includes a combination of range of motion and pain scores.

次要结局

  • Knee Society Score(3 Years)
  • Dislocation(3 Years)
  • Reports of Radiographic Loosening via Complication Form(3 Years)
  • Survivorship(3 Years)

研究者

发起方
Zimmer Biomet
申办方类型
Industry
责任方
Sponsor

相似试验